Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market to Reach $1.8 Billion, Globally, by 2031 at 4.4% CAGR: Allied Market Research

Rise in geriatric population, surge in number of minimally invasive surgeries, and increase in the number of catheterization laboratories drive the growth of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters market.


Portland, OR, May 31, 2022 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market by Product (Normal balloon catheter, Drug eluting balloon catheter, Cutting balloon catheter, Scoring balloon catheter), by Delivery Platform (Rapid Exchange (RX) / Monorail balloon catheter, Over-the-wire (OTW) balloon catheter), by Compliance (Semi-Compliant, Non-Compliant), by Balloon Material (Polyolefin copolymer (POC), Polyethylene (PE), Polyethylene terephthalate (PET)): Global Opportunity Analysis and Industry Forecast, 2021-2031”. According to the report, the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters industry generated $1.2 billion in 2020, and is anticipated to generate $1.8 billion by 2031, witnessing a CAGR of 4.4% from 2022 to 2031.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/2635

Prime determinants of growth

Rise in geriatric population, surge in number of minimally invasive surgeries, increase in hospitalization with surge in cardiovascular disorders, rise in demand for angioplasty over conventional surgeries, and increase in the number of catheterization laboratories drive the growth of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters market. Moreover, rise in technological breakthroughs & modernization in healthcare equipment and surge in healthcare research and development activities present new opportunities in the coming years.

Covid-19 Scenario

  • The outbreak of the Covid-19 pandemic has had a negative impact on the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters market, owing to a decline in the frequency of emergency and general visits linked to cardiovascular disorders.
  • Several studies revealed that the frequency of elective cardiac, neurology, and urology surgeries for the management of certain chronic diseases decreased in order to maintain the social distancing norms.

Get detailed COVID-19 impact analysis on the Percutaneous Transluminal Coronary Angioplasty (ptca) Balloon Catheters Market- https://www.alliedmarketresearch.com/request-for-customization/2635?reqfor=covid

The normal balloon catheter segment to maintain its leadership status throughout the forecast period

Based on product, the normal balloon catheter segment held the highest market share in 2020, accounting for around three-fifths of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters market, and is estimated to maintain its leadership status throughout the forecast period, owing to increase in geriatric population and surge in the occurrence of cardiovascular disease. However, the drug eluting balloon catheter segment is projected to manifest the highest CAGR of 5.3% from 2022 to 2031, due to increase in angioplasty surgeries.

The semi-compliant segment to maintain its lead position during the forecast period

Based on compliance, the semi-compliant segment accounted for the largest share in 2020, contributing to nearly four-fifths of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters market, and is projected to maintain its lead position during the forecast period. This is attributed to changes in lifestyle that lead to hypertension, obesity, and other risk factors that result in vascular disorders. However, the non-compliant segment is expected to portray the largest CAGR of 6.1% from 2022 to 2031, due to rise in demand for minimally-invasive surgeries, government initiatives, and increase in prevalence of cardiovascular disorders.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/2635

North America to maintain its dominance by 2031

Based on region, North America held the highest market share in terms of revenue 2020, accounting for more than two-fifths of the global market, owing to improved healthcare infrastructure, government initiatives, rise in the incidences of cardiac disorders, and rise in healthcare expenditure in this region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.3% from 2022 to 2031. This is due to increase in incidences of coronary heart diseases, rise in awareness regarding heart diseases and their treatments, and improvement in healthcare infrastructure in this region.

Leading Market Players: -

  • Alvi Medica
  • Abott Laboratories
  • Boston Scientific Corporation
  • Becton, Dickinson & Company
  • Ivascular
  • Ronstis
  • Koninklijke Phillips
  • Medtronic PLC
  • Balton SP Zoo
  • B. Braun Melsungen AG

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Multiplex Assays Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

PET-CT Scanner Device Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Upper Limb Prosthetics Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

COPD and Asthma Devices Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Vascular Disease Devices Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Oral Cancer Treatment Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Women Health and Beauty Supplements Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Wearable Injectors Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Computed Tomography (CT) Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Growing Utilization of Infant Phototherapy Devices in the Healthcare Industry

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220                                                            
United States
Toll Free: +1-800-792-5285                                                          
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter